Stanton Glantz, PhD's blog

Pro and con on using e-cigs to quit smoking

The New England Journal of Medicine just published two alternative views on what to tell patients about using e-cigarettes for smoking cessation, one from Chris Bullen and one from.  You can read both at http://www.nejm.org/doi/pdf/10.1056/NEJMclde1602420.
 
Check it out.

Compelling evidence that graphic warning labels on cigarettes will improve health in the US

Noel Brewer and his colleagues just published an important paper. Read more »

The White House told FDA that Black lives don’t matter

FDA courageously stated in its final version of the deeming rule that it submitted to the White House that menthol flavored products would be treated the same as other flavored products (such as chocolate and gummy bear), and therefore all newly deemed menthol products would have been ordered off of the market by November 6, 2016.  To market a flavored (including menthol) product after that date, the tobacco and e-cigarette companies would have been required to present evidence to FDA proving that the products were entitled to receive marketing authorization because they protected the Read more »

Tobacco companies consider pack color an “ingredient” that creates “new” products; FDA should learn and reject SE claims

Lauren Lempert and I just published “Packaging colour research by tobacco companies: The pack as a product characteristic” in Tobacco Control.  This paper shows that the industry treats pack color as an “ingredient” interchangeably with the contents of the physical cigarette to create “new prodcuts.”  This evidence has important implications for FDA “substantial equivalence” determinations demonstrating that changes to packaging should not be considered substantially equivalen Read more »

White House ignores science linking flavors and kid use of ecigs and other products; prioritizes business over kids health

Given how many years any new rule takes, the FDA should take the 17 pages OMB deleted from the deeming rule and issue that as a new rule right now.  You can read the changes the White House made from what the FDA wanted to do here.
 
Here is the TFK press release on the subject, which I completely support.
  Read more »

Two summer movies tagged for smoking

Since 2007, the Motion Picture Association of America's rating system has labeled a small fraction (11%) of all the US top-grossing, youth-rated movies with tobacco. This week's rating bulletin recently announced two more films labeled for smoking:
Read more »

Disney, Fox, Hearst, Time Warner tied to Philip Morris through Vice Media

Four major US media companies are tied into Vice Media Inc., a 'global youth culture' brand that works for Philip Morris International (PMI).

  Read more »

The tobacco industry knows that raising minimum age to 21 will hurt sales and worked to roll age back from 21 to 18

Dorie Apollonio and I just published “Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015” in American Journal of Public Health.  I started work on this paper skeptical that Tobacco 21 was a good idea and ended up thinking it was an important policy to pursue.  (Given how hard the tobacco companies fought it here in California was another good indication that Tobacco 21 is a good idea.)
 
Here is the abstract:
  Read more »

The tobacco industry knows that raising minimum age to 21 wll hurt sales and worked to roll age back from 21 to 18

Dorie Apollonio and I just published “Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015” in American Journal of Public Health.  I started work on this paper skeptical that Tobacco 21 was a good idea and ended up thinking it was an important policy to pursue.  (Given how hard the tobacco companies fought it here in California was another good indication that Tobacco 21 is a good idea.)
 
Here is the abstract:
  Read more »

RJ Reynolds never published a well-done randomized clinical trial of snus for smoking cessation

Eunice Neeley and I just published "RJ Reynolds has not published a negative randomised clinical trial of Camel Snus for smoking cessation" in Tobacco Control.   This paper uses previously secret tobacco industry documents to track the design and completition of a trial RJR did that, had it been positive, could have supported a claim that snus was effective for smoking cessation, thus bolstering the widely-made claim in harm reduction circles that snus was good for har Read more »

Syndicate content